Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02751866

Early Intervention in Cognitive Aging

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Nutritional intervention in overweight middle aged individuals with subjective memory complaints.

Detailed description

Late-onset AD develops over many years during a preclinical period in which neuropathological changes accumulate before dementia is evident. Deposition of amyloid-beta (Aβ) in the brain is the earliest recognized biomarker of AD pathology, and, demographically, Aβ accumulation begins to accelerate at age 50, a period when the incidence of metabolic disturbance increases as well. Hyperinsulinemia associated with insulin receptor resistance has been associated with AD pathololgy, and metabolic disturbance in mid-life increases risk for subsequent dementia. There are indications that subjective memory complaints can be an early indicator of developing neuropathology and may be the first manifestation of future dementia. This research involves intervention studies in different samples of individuals from this population to investigate the extent to which berry fruit supplementation and ketone metabolism might improve cognitive performance in association with enhancement of metabolic function and related factors. The ultimate goal of this research is to develop interventional approaches that might be applied with at-risk individuals in the preclinical period of dementia to forestall or prevent progression of neurocognitive decline.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBerry fruit powder OR nutritional ketosisDaily supplementation with berry fruit powder OR carbohydrate restriction to achieve nutritional ketosis
DIETARY_SUPPLEMENTPlacebo powder OR higher carbohydrateDaily supplementation with placebo powder OR higher carbohydrate intake

Timeline

Start date
2016-01-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2016-04-26
Last updated
2025-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02751866. Inclusion in this directory is not an endorsement.